Immunotherapy for gastrointestinal malignancies

PG Toomey, NA Vohra, T Ghansah… - Cancer …, 2013 - journals.sagepub.com
Background Gastrointestinal (GI) cancers are the most common human tumors encountered
worldwide. The majority of GI cancers are unresectable at the time of diagnosis, and in the …

Cancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers

A Salmaninejad, MR Zamani… - Immunological …, 2016 - Taylor & Francis
Cancer/testis antigens (CTAs) are named based on their expression pattern that is restricted
in a number of normal and abnormal tissues. Tumor cells frequently express antigens whose …

High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma

X Gu, M Fu, Z Ge, F Zhan, Y Ding, H Ni, W Zhang… - Scientific reports, 2014 - nature.com
Abstract Melanoma-associated antigens (MAGE)-A9 has been reported to play important
roles in the development of human cancers. However, the association between MAGE-A9 …

MAGE-A family: attractive targets for cancer immunotherapy

M Sang, Y Lian, X Zhou, B Shan - Vaccine, 2011 - Elsevier
The melonoma-associated antigens family A (MAGE-A) belongs to cancer/testis antigens
(CTA) that are expressed in a wide variety of malignant tumors but not in normal adult …

Discovery and structural basis of the selectivity of potent cyclic peptide inhibitors of MAGE-A4

MC Fleming, LF Chiou, PP Tumbale… - Journal of medicinal …, 2022 - ACS Publications
MAGE proteins are cancer testis antigens (CTAs) that are characterized by highly conserved
MAGE homology domains (MHDs) and are increasingly being found to play pivotal roles in …

[HTML][HTML] Cancer-testis antigen peptide vaccine for cancer immunotherapy: progress and prospects

X Wei, F Chen, K Xin, Q Wang, L Yu, B Liu, Q Liu - Translational oncology, 2019 - Elsevier
Cancer vaccines, including peptide-based vaccines, have been considered a key tool of
effective and protective cancer immunotherapy because of their capacity to provide long …

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers

H Ai, H Yang, L Li, J Ma, K Liu, Z Li - Frontiers in Immunology, 2023 - frontiersin.org
Digestive tract cancers, including esophageal, gastric, and colorectal cancers, are the major
cause of death among cancer patients worldwide due to the heterogeneity of cancer cells …

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy

Y Zhang, Y Zhang, L Zhang - Journal of cancer research and clinical …, 2019 - Springer
Purpose Esophageal cancer is a common disease in China with low survival rate due to no
obvious early symptoms and lack of effective screening strategies. Traditional treatments …

Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma

Q Wang, C Ma, W Kemmner - BMC cancer, 2013 - Springer
Background We attempted to identify novel biomarkers and therapeutic targets for
esophageal squamous cell carcinoma by gene expression profiling of frozen esophageal …

Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma

J Xu, C Zhu, Y Yu, W Wu, J Cao, Z Li, J Dai, C Wang… - …, 2019 - thelancet.com
Background Esophageal squamous cell carcinoma (ESCC) is one of the most lethal
malignancies with poor prognosis. Cancer-testis genes (CTGs) have been vigorously …